Muc3

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Muc3 trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (2 shown)

TerminatedPhase 1

NCT04117958

Study of AMG 199 in Subjects With MUC17-Positive Solid Tumors Including Gastric, Gastroesophageal Junction, Colorectal,…

To evaluate the safety and tolerability of AMG 199 in adult subjects and to determine the maximum tolerated dose (MTD) and/or recommended phase 2 dose (RP2D).

United States, Austria, France58 participantsStarted 2020-01-20

Treatment: AMG 199

CompletedNot Applicable

NCT04421183

Investigation of the Serum Mucoprotein 3 (MUC3) Protein Levels in Gestational Hypertensive Disease

Hypertensive diseases of pregnancy are one of the most frequently encountered reasons for maternal and neonatal morbidity and mortality. The excretion of high l…

Turkey (Türkiye)80 participantsStarted 2010-06-01

Treatment: draw blood